Navigation Links
Germany Prioritizes Medical Biotechnology with New Initiatives
Date:9/17/2012

BERLIN and BOSTON, September 17, 2012 /PRNewswire/ --

The new round of funding by Germany's Ministry of Education and Research will provide EUR 40 million for biotechnology research. At the same time, the Health - Made in Germany initiative has been set up to turn Germany into a business hub for the international healthcare industry. With these new initiatives, Germany is consolidating its position as Europe's top medical biotechnology location.

"We are hosting a breakfast seminar on September 18 in Boston to bring together important players from the German and American biotechnology sectors. One of Germany's top clusters, BioM Munich and Massachusetts association MassBio will have a chance to highlight bilateral ties. This meeting will be a great start to this year's BioPharm America 2012, happening from September 19-21 in Boston," stated Sandra Buetow, pharmaceutical industry expert for Germany Trade & Invest in Berlin.

Germany features over 500 dedicated biotechnology companies. Nearly half of these companies develop new drugs or diagnostic methods in the areas of human and animal medicine, making this one of the most important applications of biotechnology. The United States is the top investor in Germany, according to Germany Trade & Invest statistics. At the same time, the USA is an essential market for German exports.

Health - Made in Germany is an initiative to create win-win situations for global partners and German healthcare companies. Supported by the Federal Ministry of Economics and Technology and carried out by Germany Trade & Invest, the initiative allows companies, federal clusters, and professional associations to benefit from business opportunities in the healthcare field.

Germany Trade & Invest is the foreign trade and inward investment promotion agency of the Federal Republic of Germany. The organization advises foreign companies looking to expand their business activities in the German market. It provides information on foreign trade to German companies that seek to enter foreign markets.

Germany Trade & Invest
Andreas Bilfinger
Email: andreas.bilfinger@gtai.com
T: +49(0)30-200099-173
http://www.gtai.com/press-subscription
http://twitter.com/gtai_com
http://youtube.com/gtai


'/>"/>
SOURCE Germany Trade and Invest
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany
2. World record: Scientists from northern Germany produce the lightest material in the world
3. Marken Opens Two Pharmaceutical Depots In New York & Germany
4. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
5. DiaTech Life Sciences Announces Medical Advisory Board
6. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
7. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
8. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
9. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
10. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
11. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... , Jan. 23, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: ... into an underwriting agreement with Rodman & Renshaw, a ... as sole book running manager and representative of several underwriters, ... a firm commitment basis a minimum of 2,105,264 shares ... to purchase a minimum of 1,052,632 shares of common ...
(Date:1/23/2017)... 2017 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or the "Company") ... New Zealand based Phase 1 trial ... remarkable results in reducing inflamed protein biomarkers in patients ... is believed that this is the first time in ... can be made between epigenetic regulation and its potential ...
(Date:1/23/2017)... ... 2017 , ... AxioMed will be presenting its viscoelastic cervical ... Montego Bay, Jamaica from January 26-28th. “We’re excited to be presenting the benefits ... the simplicity of the surgical technique,” said Jake Lubinski, President of AxioMed. ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... to bring to market a pioneering medical device for the treatment of Age-Related ... engagement contract with Emergo, a global regulatory consultancy that helps companies like ours ...
Breaking Biology Technology:
(Date:1/12/2017)... Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... technologies, today announced that it has signed agreements with ... and the Middle East for ... marks the first wave of international distribution agreements for ... blood samples. The initial partners will introduce ...
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
(Date:1/3/2017)... 3, 2017 Onitor, provider of digital health ... Track, an innovative biometric data-driven program designed to aid ... at the 2017 Consumer Electronics Show (CES) in ... the U.S., the World Health Organization (WHO), have identified ... adults who are overweight or obese. WHO also states ...
Breaking Biology News(10 mins):